That the House of Representatives—
expresses support for the designation of “DES Awareness Week”;
recognizes the history of the drug diethylstilbestrol and the harm it has caused;
supports the restoration of funding for the DES Follow-Up Study; and
urges the Food and Drug Administration to issue a formal apology to families impacted by diethylstilbestrol.